AuthorsLajtha, L G
AffiliationPaterson Laboratories, CHristie Hospital and Holt Radium Institute, Withington, Manchester, M20 9BX, UK
MetadataShow full item record
AbstractTwo features are known about acute myeloid leukaemia in man: (1) the long time-scale from identifiable leukaemogenic stimulus and onset of the clinical disease and (2) the successful induction and duration of long clinical remission. These indicate three probabilities: First, that the target cell for leukaemogenetic insult (in AML) is the pluripotent stem cell; second, that the leukaemic stem line is a small minority population within the total leukaemic cell mass; third, when the leukaemic stem line is not greatly exceeding the normal stem cell numbers, its proliferation may be still under partial control.
CitationWhich are the leukaemic cells? 1981, 7 (1):45-62 Blood Cells
- Acute leukaemia: development, remission/relapse pattern, relationship between normal and leukaemic haemopoiesis, and the 'sleeper-to-feeder' stem cell hypothesis.
- Authors: Killmann SA
- Issue date: 1991 Jul
- Stem cell renewal and differentiation in acute myeloblastic leukaemia.
- Authors: McCulloch EA, Minden MD, Miyauchi J, Kelleher CA, Wang C
- Issue date: 1988
- Generation time of leukaemic blast progenitor cells.
- Authors: Minden M, Major P, Griffin J, Wu A, Kufe D
- Issue date: 1983 Nov
- Cancer stem cells: lessons from leukaemia.
- Authors: Bonnet D
- Issue date: 2005 Dec
- Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
- Authors: Neudenberger J, Hotfilder M, Rosemann A, Langebrake C, Reinhardt D, Pieters R, Schrauder A, Schrappe M, Röttgers S, Harbott J, Vormoor J
- Issue date: 2006 May